Gene · 53947
Papers2,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case Report: Concurrent Fabry disease, IgA nephropathy and undifferentiated connective tissue disease in a female with normal enzyme activity. | Front Immunol | 2026 | 42824490 | PubTator, text mining | PubMed |
| A novel P1PK-null allele in a Belgian patient with a p phenotype. | Transfusion | 2026 | 42678021 | PubTator, text mining | PubMed |
| Central nervous system biomarkers in Fabry disease: Mechanisms, clinical evidence, and translational integration. | Mol Genet Metab | 2026 | 42623976 | PubTator, text mining | PubMed |
| Surface Functionalization of Small Extracellular Vesicles Derived from Caco-2 and HEK293T Cells in the Neutralization of Shiga Toxin 1 Subunit B. | Bioconjug Chem | 2026 | 42615512 | PubTator, text mining | PubMed |
| Unraveling A4GALT Mechanism and Its Modulation With Adamantyl-Galactosylceramide Analogues: Advancing Fabry Disease Therapeutic Strategies. | Angew Chem Int Ed Engl | 2026 | 42559965 | PubTator, text mining | PubMed |
| Evaluating the relationship between antidrug antibodies and efficacy and safety outcomes in patients with Fabry disease receiving enzyme replacement therapy: a systematic literature review. | Orphanet J Rare Dis | 2026 | 42464344 | PubTator, text mining | PubMed |
| Functional dissection of HCMV gB's autonomous fusion activity provides insights into how polymorphisms in clinical isolates confer distinct characteristics. | mBio | 2026 | 42439560 | PubTator, text mining | PubMed |
| ECG parameters to detect cardiac involvement in Fabry disease. | BMC Cardiovasc Disord | 2026 | 42436424 | PubTator, text mining | PubMed |
| Pathogenic mechanisms in Fabry disease. | Front Med (Lausanne) | 2026 | 42415779 | PubTator, text mining | PubMed |
| Automated quantification of skin Gb3 load and white matter lesion assessment in Fabry disease. | Orphanet J Rare Dis | 2026 | 42415116 | PubTator, text mining | PubMed |
| Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients. | J Inherit Metab Dis | 2026 | 42324896 | PubTator, text mining | PubMed |
| A Rare Case of Fabry Disease Combined With Idiopathic Multicentric Castleman Disease and Membranous Nephropathy. | Kidney Med | 2026 | 42290669 | PubTator, text mining | PubMed |
| Modeling Fabry nephropathy: insights from experimental systems towards precision nephrology. | Dis Model Mech | 2026 | 42212514 | PubTator, text mining | PubMed |
| Nanomedicines for DNA and interference RNA co-delivery: Combined gene therapy for Fabry disease. | Int J Pharm X | 2026 | 42170556 | PubTator, text mining | PubMed |
| A proteomic atlas phenotyping Fabry disease identifies a precise cardiovascular risk signature that integrates mitochondrial and lysosomal pathways. | J Mol Med (Berl) | 2026 | 42168444 | PubTator, text mining | PubMed |
| Globotriaosylceramide (Gb3) implications in cardiovascular disease for its mechanistic insights, food chemistry aspects and clinical significance - A review. | Int J Biol Macromol | 2026 | 42142780 | PubTator, text mining | PubMed |
| Targeting StxB-mediated intracellular trafficking as a pharmacological strategy for anti-virulence intervention. | Microb Pathog | 2026 | 42082085 | PubTator, text mining | PubMed |
| A Rare Case of P-Null Phenotype Identified During Preoperative Screening. | Clin Case Rep | 2026 | 42078824 | PubTator, text mining | PubMed |
| Hydroxychloroquine-induced renal phospholipidosis manifesting as proximal tubulopathy in systemic lupus erythematosus. | BMC Nephrol | 2026 | 42071197 | PubTator, text mining | PubMed |
| Beneficial bystander-enhanced cryptic splice rescue of cardiac-type Fabry GLA IVS4+919G>A by adenine base editing in patient fibroblasts. | Gene Ther | 2026 | 42000856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53947/papers